Form 4: Director Kristina Burow Exercises Scholar Rock Options

Director Kristina Burow exercised stock options for 89,800 shares of Scholar Rock Holding Corp common stock on April 23, 2026.

Summary

• Director Kristina Burow exercised stock options to acquire a total of 89,800 shares of Scholar Rock Holding Corp (SRRK) common stock.
• The exercises occurred across four separate tranches with exercise prices ranging from $4.75 to $26.78 per share.
• Following these transactions, the reporting person holds 110,871 shares directly and maintains an indirect interest in 2,345,711 shares held by ARCH Venture Fund VIII, L.P.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents the routine exercise of vested equity compensation by a director.

Positives

• Director demonstrates continued commitment to the company through the exercise of vested equity incentives.
• The exercise of options increases the director's direct equity stake in the company.

Negatives

• None identified; this is a standard exercise of vested employee/director stock options.

Risks

• The reporting person maintains a significant indirect interest in the company through ARCH Venture Fund VIII, L.P., which may be subject to future liquidity events or portfolio rebalancing.

Future Outlook

No forward-looking guidance or strategic outlook provided in this filing.

Industry Context

StockSavvy.ai notes that insider option exercises are common in the biotechnology sector as directors and executives manage their equity compensation packages, and this specific filing reflects standard administrative activity rather than a change in strategic direction.

Comparison to Industry Standards

• The exercise of vested stock options by board members is a standard corporate governance practice in the life sciences industry.
• The transaction volume is consistent with typical director equity management patterns for mid-cap biotech firms.

Related Party Transactions

• The reporting person is a managing director of ARCH Venture Partners VIII, L.P., which holds 2,345,711 shares of the issuer.

Stakeholder Impact

• Minimal impact on shareholders as the transaction involves the exercise of existing vested options rather than new share issuance or open market sales.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

Scholar Rock, SRRK, Form 4, Insider Trading, Stock Options, Equity Compensation, Biotech